Equiposa (Cannabis flos Aurora): dried flower with equal declaration of THC and CBD

Where does Equiposa come from and who are its parents?

Unknown. Neither budcare.pl nor medweed.pl provide the parents of this strain, so in our ancestry graph, it is listed with an undetermined value. The breeder of the cross has not disclosed it, and guessing based on the sound of the trade name would create false connections between sources, connections that are not confirmed by any available study.

However, it can be said what this product is in the pharmacy. Both databases list it under the registered name Cannabis flos Aurora Deutschland GmbH, and in commercial descriptions, it appears as Aurora 8/8. The manufacturer's declaration is aligned here: the nominal THC content and nominal CBD content are identical in both databases, and when accounting for the permissible deviation from the declared value, the THC range is 7.2-8.8%. The same calculation applies to the second of these compounds, as one of the sources records the tolerance directly next to both numbers.

On one point, both descriptions diverge. budcare.pl classifies Equiposa as a hybrid with a sativa dominance, while medweed.pl classifies it as a regular hybrid, without indicating dominance. This cannot be resolved without a pedigree, and since there is no pedigree, we present both classifications side by side instead of choosing the more convenient one. We maintain a complete list of strains along with established and unestablished origins in the list of strains available in Polish pharmacies.

How many producers supply Equiposa to Polish pharmacies?

One. Equiposa is exclusively supplied by Aurora, and it corresponds to a single pharmacy position, not a family of variants with different strengths, as is found with more popular names. Both databases we use describe exactly the same position and only diverge in the recording of the trade name and the assigned genetics.

The table compares what each database recorded about the same pharmacy position. The differences do not concern the raw material, but the diligence of the record: one database notes the declaration tolerance and the status of the position, while the other only includes the name and the list of profile ingredients.

Status has practical significance here. budcare.pl marks Equiposa as a discontinued product, meaning it could not be purchased at the pharmacy at the time of data recording. This is not a characteristic of the strain, but rather a snapshot of the market at one moment: the permit for the raw material is valid for five years and can be revoked earlier, wholesalers run out of batches, and the manufacturer can withdraw a product from one market and leave it on another. Therefore, in this text, we do not claim that Equiposa is or is not available for purchase today; we maintain the current status in one place and only update it there. Separately we describe the entire assortment of this manufacturer.

Two things with similar names can easily be confused: retail dried flower belongs to a different product category than the pharmacy raw material dispensed by a doctor's prescription, which is discussed in this text, and there will be no position like this in it.

How does Equiposa smell and taste?

Earthy, with a distinct pine note. The budcare.pl database assigns four aroma descriptors to this strain: earthy, piney, peppery, and minty. This description comes from the data provider, not from measurement, and medweed.pl does not provide any scent characteristics for this item that could be compared.

These descriptors can be translated into names from the profile, although the translation is an approximation, not an assignment of scent to a molecule. The pine note corresponds to the presence of pinene, the peppery to caryophyllene, the earthy and slightly herbal to myrcene, and the citrusy to limonene. The floral accent is often associated with linalool, but linalool is contentious in this profile.

It is precisely in the composition of the profile that both databases differ from each other. medweed.pl lists five names and places myrcene at the top of its weight order, ahead of pinene, limonene, linalool, and caryophyllene. budcare.pl lists four and does not include linalool among them. The discrepancy concerns not the proportions, but whether a given compound is present in this strain at all. Each of them has its own text in this comparison about what has been shown for it: pinene, caryophyllene, limonene, linalool and myrcene.

We do not provide percentage shares for these names, and this is a decision, not an oversight. Polish databases publish numbers for some items, but the sum of these numbers for one strain can be completely different depending on the database: we checked three such comparisons, and the sums ranged from forty-six to eighty-three percent. The denominator remains unknown, and a number without a denominator in the text about the raw material issued by a doctor's prescription looks like a measurement, which it is not.

How long does it take for Equiposa to start working and how long does it last?

From a few minutes to two hours, depending on how the raw material is consumed. No one has published such a measurement for Equiposa itself, so the following ranges describe the method of administration, common for all medicinal dried flowers, and not the property of this specific strain or its profile.

The route of administration determines the course more than the variety itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect lasts for two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode can last six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and takes another dose will receive both doses at once. The above ranges describe the route of administration, not this variety; pharmacokinetic studies for a single cultivar have not been published.

For this item, there is one circumstance that changes the reading of the above ranges: the THC declaration is among the lowest in the entire comparison and falls within the range of 7.2-8.8%. A lower declaration does not shift the moment when the first sensations appear, nor does it shorten the episode, as both are determined by the method of administration. However, it changes the amount of substance per the same dose of raw material. The method of intake and the size of the dose are determined by the attending physician, not the strain description.

What is known about the effects of Equiposa from research, and what comes from commercial descriptions?

From research, nothing is known that pertains exclusively to this strain. Not a single study has been published on Equiposa, so the evidence we have concerns individual compounds identified in its profile or hemp flower in general. Everything else is a description from the data provider or a patient report.

The commercial description in the budcare.pl database assigns possible stimulating and balancing effects to this item. Two descriptors pulling in different directions stand there side by side without a given basis, so we treat them as a sales label, not as an observation.

Separately stands what has been studied for myrcene itself, a compound placed by both databases at the top of this profile. The three studies below were conducted on mice, not on humans. do Vale et al., Phytomedicine 2002, PMID:12587690: Myrcene administered intraperitoneally (100-200 mg/kg) reduced the locomotor activity of mice in the open field test, prolonged sleep induced by pentobarbital (at 200 mg/kg about 2.6 times), and reduced the number of entries into the open arms of the elevated plus maze, which the authors described as a weak anxiogenic effect, not anxiolytic.

Rao et al., Journal of Pharmacy and Pharmacology 1990, PMID:1983154: Myrcene (10-40 mg/kg) reduced pain responses in mice in the hot plate and writhing tests induced by acetic acid; the effect was reversed by naloxone and yohimbine, indicating the involvement of alpha2-adrenergic receptors and the release of endogenous opioids.

Wagner et al., NeuroSci 2024, PMID:39728677: With short puffs of vapor, mimicking inhalation in humans, beta-myrcene acted anxiolytically in the elevated plus maze in female mice, and in males only with a single puff. Unlike linalool, myrcene did not produce a synergistic effect with cannabidiol in either sex.

In humans, myrcene alone has not been shown to alleviate insomnia at doses typical for inhalation of dried flower. The direction of the effect in rodents depends on the route of administration and sex: intraperitoneal injection in 2002 described a slightly anxiogenic effect, while inhalation in 2024 showed an anxiolytic effect in females. These two results do not negate each other; they simply show that the conclusion depends on conditions that no popular strain database provides.

What side effects have been reported after using Equiposa?

None that could be attributed specifically to this name. The adverse event registry identifies the drug by batch number, not by cultivar, so there is no separate statistic for Equiposa. What follows below describes hemp flower as a group of raw materials and applies equally to every item from the pharmacy.

Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.

A low THC declaration does not remove this item from the above description. The listed symptoms have been reported with raw materials of very different declarations, and the threshold at which they appear is a personal matter, not a property of the trade name. A report of suspected adverse effects is accepted by a doctor or pharmacist, and they are the ones who pass it on.

What do the boiling points of the compounds in this profile say about vaporization?

Less than what popular tables promise. The compounds marked in the Equiposa profile have boiling points ranging from about 156 to 258 degrees Celsius, but the boiling point is not the threshold for initiating vaporization; it is the temperature at which the vapor pressure equals the ambient pressure.

The numbers in the table come from a public database of chemical compounds and describe the pure compound at atmospheric pressure, not the same compound enclosed in a vaporizer chamber. Two factors make it impossible to directly transfer them to equipment settings. First, vaporization occurs well below the boiling point, and its rate increases with temperature in a way far from a threshold jump. Second, the number displayed by the vaporizer describes the heating element or air, not the dried flower itself, which is cooled by the airflow when inhaled and heats unevenly. No one has publicly measured the difference between the two.

Additionally, there is a problem specific to this strain. Since one source lists linalool and the other does not recognize it, aiming for its temperature would be targeting a component whose presence in this profile no one has confirmed. We develop both threads separately, in the text about the evaporation of terpenes and in the text about the difference between the equipment setting and the temperature of the dried flower. The method of administration is determined by the attending physician.

Which strains are related to Equiposa?

None, whose relationship could be demonstrated. The pedigree chart in this comparison connects strains through common parents named by name, and Equiposa has no such parents, so its sibling list remains empty and will remain so until the breeder reveals the cross. This empty list is a result, not a gap to be filled.

An empty list can easily be mistaken for a lack of data, though these are two different things. With a strain of known pedigree, an empty list usually means that the parents are landraces or broad style families that do not designate siblings because they are categories, not individual crosses. With Equiposa, it’s something simpler: we do not know the first link, so there is nothing to start counting from.

Two similarities that can easily be mistaken for kinship are not kinship. Aurora also supplies Delahaze, Farm Gas, and Ghost Train Haze to Polish pharmacies, but the common manufacturer speaks of the supply channel, not genetics; we explore this topic in a separate text about odmianach tego dostawcy. The situation is similar with myrcene: it is shared with Equiposa by nineteen other products from this list, and what this implies and what it does not imply is resolved in the text dedicated to it mircenowi. We maintain a compilation of all strains along with their origins in a separate, updated list.

Frequently Asked Questions about Equiposa

Does Equiposa have a defined pedigree?

No. Neither of the two sources describing this strain provides its parents, so it appears as unspecified in our lineage graph. The commercial name of the pedigree does not replace this.

How many manufacturers supply Equiposa to pharmacies in Poland?

One. Aurora leads the position and corresponds to one entry in our pharmacy listing, without variants of different strengths.

Why do you provide the THC content as a range rather than a single number?

Because the manufacturer's declaration has a tolerance of about ten percent of the value. For this position, it gives a range of 7.2-8.8%, rather than a single number that would appear to be a measurement result.

Do you provide percentage shares for the terpenes in Equiposa?

No. The total shares published by Polish databases for the same positions diverge enough that it is unclear what they refer to, so we only provide the composition.

Is Equiposa available in Polish pharmacies?

One of the sources marks this position as withdrawn, and the current status changes faster than the text can be updated. We maintain an up-to-date list in our comparison of strains available in Polish pharmacies.

Have there been clinical studies using Equiposa?

No. No studies conducted on this strain have been published. Available evidence pertains to individual compounds marked in its profile and comes from studies on rodents.

The material is for informational purposes only and does not replace medical advice. Dried flower is a pharmaceutical raw material dispensed by a doctor's prescription in the Rpw category, and the choice of raw material and method of administration is determined by the attending physician. Editorial text: redakcja ubucha.pl.